212 related articles for article (PubMed ID: 28687572)
1. Point: The Imprecise Pursuit of Precision Medicine: Are Biomarkers to Blame?
Gyawali B
J Natl Compr Canc Netw; 2017 Jul; 15(7):859-862. PubMed ID: 28687572
[No Abstract] [Full Text] [Related]
2. Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit.
Kato S; Subbiah V; Kurzrock R
J Natl Compr Canc Netw; 2017 Jul; 15(7):863-866. PubMed ID: 28687573
[No Abstract] [Full Text] [Related]
3. Giving Up on Precision Oncology? Not So Fast!
Warner JL
Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
[No Abstract] [Full Text] [Related]
4. Achieving the goals of effective, safe, and individualized cancer care.
Roberts SA; Karnes EK; Allen JD; Benner JS; Sigal EV; McClellan M
Clin Cancer Res; 2011 Nov; 17(21):6632-3. PubMed ID: 22046023
[No Abstract] [Full Text] [Related]
5. New ESMO scale ranks mutations as cancer medicine targets.
Fricker J
Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495
[No Abstract] [Full Text] [Related]
6. Maurie Markman on the Groundbreaking TAPUR Trial.
Markman M
Oncology (Williston Park); 2017 Mar; 31(3):158, 168. PubMed ID: 28299751
[No Abstract] [Full Text] [Related]
7. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
8. Precision and predictive medicine in urothelial cancer: are we making progress?
Bellmunt J; Orsola A; Sonpavde G
Eur Urol; 2015 Oct; 68(4):547-9. PubMed ID: 25935702
[TBL] [Abstract][Full Text] [Related]
9. Pairing Cancer Biomarkers to Biomedicine.
Shin SH; Dong Z
EBioMedicine; 2017 Nov; 25():1-2. PubMed ID: 29113773
[No Abstract] [Full Text] [Related]
10. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
11. Biomarker threshold adaptive designs for survival endpoints.
Diao G; Dong J; Zeng D; Ke C; Rong A; Ibrahim JG
J Biopharm Stat; 2018; 28(6):1038-1054. PubMed ID: 29436940
[TBL] [Abstract][Full Text] [Related]
12. Optimizing access to matched therapies.
Romero D
Nat Rev Clin Oncol; 2019 Jul; 16(7):401. PubMed ID: 31053773
[No Abstract] [Full Text] [Related]
13. Precision Medicine.
Khatri VP; Petrelli NJ
Surg Oncol Clin N Am; 2020 Jan; 29(1):xv-xvi. PubMed ID: 31757318
[No Abstract] [Full Text] [Related]
14. Preface on application of omics technologies in cancer biology and therapy.
Georgakilas AG
Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
[No Abstract] [Full Text] [Related]
15. Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.
Schachtschneider KM; Gaba RC
J Vasc Interv Radiol; 2018 Aug; 29(8):1117-1121. PubMed ID: 30055782
[No Abstract] [Full Text] [Related]
16. Precision medicine: In need of guidance and surveillance.
Lin JZ; Long JY; Wang AQ; Zheng Y; Zhao HT
World J Gastroenterol; 2017 Jul; 23(28):5045-5050. PubMed ID: 28811702
[TBL] [Abstract][Full Text] [Related]
17. Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice.
Beer PA; Cooke SL; Chang DK; Biankin AV
Ann Oncol; 2019 Nov; 30(11):1691-1694. PubMed ID: 31665210
[No Abstract] [Full Text] [Related]
18. Is Precision Medicine an Oxymoron?
Eckhardt SG; Lieu C
JAMA Oncol; 2019 Feb; 5(2):142-143. PubMed ID: 30419105
[No Abstract] [Full Text] [Related]
19. Steps forward for cancer precision medicine.
Salgado R; Moore H; Martens JWM; Lively T; Malik S; McDermott U; Michiels S; Moscow JA; Tejpar S; McKee T; Lacombe D;
Nat Rev Drug Discov; 2018 Jan; 17(1):1-2. PubMed ID: 29170471
[TBL] [Abstract][Full Text] [Related]
20. [Adaptive designs for innovative therapies assessment: New methodological challenges].
Asselain B
Bull Cancer; 2018 Sep; 105(9):741-742. PubMed ID: 30146086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
